Australia markets closed

Actinogen Medical Limited (ACW.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0250+0.0010 (+4.17%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 56.35M
Enterprise value 47.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.20
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.64

Trading information

Stock price history

Beta (5Y monthly) 2.22
52-week change 3-78.26%
S&P500 52-week change 312.18%
52-week high 30.1200
52-week low 30.0150
50-day moving average 30.0203
200-day moving average 30.0414

Share statistics

Avg vol (3-month) 32.32M
Avg vol (10-day) 31.78M
Shares outstanding 52.25B
Implied shares outstanding 62.25B
Float 81.37B
% held by insiders 119.57%
% held by institutions 114.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 303 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin -219.98%
Operating margin (ttm)-90.23%

Management effectiveness

Return on assets (ttm)-35.65%
Return on equity (ttm)-61.18%

Income statement

Revenue (ttm)4.89M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)4.89M
EBITDA -10.66M
Net income avi to common (ttm)-10.75M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.46M
Total cash per share (mrq)0
Total debt (mrq)86.93k
Total debt/equity (mrq)0.65%
Current ratio (mrq)7.04
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-8.7M
Levered free cash flow (ttm)-4.86M